Antipsychotic treatment- side effect and/or metabolic syndrome

Dadić-Hero, Elizabeta; Ružić, Klementina; Grahovac, Tanja; Žarković-Palijan, Tija; Petranović, Duška; Šepić-Grahovac, Dubravka

Pregled bibliografske jedinice broj: 508399

Antipsychotic treatment- side effect and/or metabolic syndrome

Dadić-Hero, Elizabeta; Ružić, Klementina; Grahovac, Tanja; Žarković-Palijan, Tija; Petranović, Duška; Šepić-Grahovac, Dubravka

Antipsychotic treatment- side effect and/or metabolic syndrome // Psychiatria Danubina, 23 (2011), 1; 98-100 (podatak o recenziji nije dostupan, prikaz, stručni)

CROSBI ID: 508399 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Antipsychotic treatment- side effect and/or metabolic syndrome

Autori
Dadić-Hero, Elizabeta ; Ružić, Klementina ; Grahovac, Tanja ; Žarković-Palijan, Tija ; Petranović, Duška ; Šepić-Grahovac, Dubravka

Izvornik
Psychiatria Danubina (0353-5053) 23 (2011), 1; 98-100

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, prikaz, stručni

Ključne riječi
schizophrenia; atypical antipsychotics; side effects

Sažetak
According to current medical opinion chronic mental diseases such as schizophrenia require life-long treatment. The choice of antipsychotics is an important treatment factor, since their side-effects often influence patients’ compliance with treatment. Severe side-effects may cause the patients to reject such treatment, the latter being their right. In case a psychiatrist does not agree with the patient’s decision to interrupt his antipsychotic treatment regardless its serious side-effects, the former should be persistent in convincing the patient to replace such drug with a more appropriate therapy.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti

POVEZANOST RADA

Ustanove:
Medicinski fakultet, Rijeka

Profili:

Tija Žarković Palijan (autor)